WithdrawnPHASE1, PHASE2NCT04144335

N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIV

Studying Acquired immunodeficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Minnesota
Principal Investigator
Timothy Schacker, MD, LMFT
Medical School, University of Minnesota
Intervention
N-803 and bNAbs(biological)
Eligibility
18 years · All sexes
Timeline
20202020

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04144335 on ClinicalTrials.gov

Other trials for Acquired immunodeficiency

Additional recruiting or active studies for the same condition.

See all trials for Acquired immunodeficiency

← Back to all trials